BioSpace News Archive

Job Trends

Study Demonstrating Accuracy of DecisionDx-Melanoma Prognostic Test Across Melanoma Tissue Sources Presented at the American Society of Dermatopathology 55th Annual Meeting

Castle Biosciences, Inc. today announced study results showing that the DecisionDx-Melanoma test accurately predicts risk for patients with cutaneous melanoma when using either biopsy or wide local excision (WLE) as the tissue source.

November 13, 2018
·
4 min read
Business

Agilvax Appoints Joseph Patti, Ph.D. as Executive Chairman

Adds significant drug and business development experience to Agilvax as it transitions into a clinical stage company

November 13, 2018
·
2 min read
Business

Tiger Group and Liquidity Services Launch ‘Powerhouse Partnership’ Focused on Distressed Assets in Biopharma

--Newly formed Tiger Liquidity Services Biopharma Partners broadens options for turnaround and insolvency professionals working in the sector

November 13, 2018
·
3 min read
Business

Palatin Technologies, Inc. Reports First Fiscal Quarter 2019 Results and Provides Corporate Update

Teleconference and Webcast to be held on November 13, 2018

November 13, 2018
·
10 min read
BioForest

Red Cross Issues Urgent Call for Blood Donations Heading into Holiday Season

21,000 fewer blood donations collected during September and October than needed

November 13, 2018
·
4 min read
BioCapital

AsclepiX Therapeutics Raises $5M in New Funding

Financing will advance clinical development of the Company’s lead product AXT107

November 13, 2018
·
4 min read
China Pharma Holdings, Inc. Launched Health Product Noni Enzyme ARARATO®

China Pharma Holdings, Inc. announced today the launch of its health product Noni Enzyme ARARATO® to the market.

November 13, 2018
·
3 min read
Drug Development

Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection

First Patient has Completed Dosing in Global Phase 2 Clinical Trial for the First-Line Treatment of Patients with Candidemia

November 13, 2018
·
3 min read
Business

INVO Bioscience Enters Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel INVOcell™ System for Use in the Treatment of Infertility

INVO Bioscience, Inc. and Ferring Pharmaceuticals announced today that the companies have entered into an exclusive U.S. commercialization rights agreement for INVOcell.

November 13, 2018
·
5 min read
FDA

Bio2 Technologies, Inc. Receives FDA IDE Approval to Begin Clinical Study of Resorbable Cervical Interbody Device for Spinal Fusion

Vitrium® - a structurally stable, fully resorbable autogenic-biomatrix

November 13, 2018
·
2 min read